Suppliers / Vistin Pharma

Vistin Pharma

Norway 53 employees Updated 9 July 2026

Vistin Pharma is an API manufacturer based in Norway. It holds 2 active US drug master files and one valid CEP. Its GMP standing is certified by EMA.

2
active US DMFs
1
valid CEPs
3
registered plants
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Sannidal, Norway Not on file
OSLO, Norway Not on file
OSLO, Norway Not on file

What they file, and where

Molecule Regulators Docs
Metformin EDQM, US FDA 3

Also appears on these molecule pages

Metformin API

Filings and GMP by regulator

Regulator Filings GMP certificates
NCELS (KZ) 1 None
EMA None 1

Scale

Year Revenue Exports Destinations
2024 $39.9M Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Comparing suppliers?

Choose your molecules and target markets. Vistin Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported